Abstract:
Objective: To investigate the predictive value of haemoglobin and albumin levels and lymphocyte and platelet (HALP) counts in gastric cancer patients. Study Design: Descriptive study. Place and Duration of Study: Department of Gastroenterology, Zonguldak Bulent Ecevit University, Faculty of Medicine, Zonguldak, Turkey, from January 2017 to January 2022. Methodology: Clinical data of 204 patients with gastric cancer were reviewed. The median value of the HALP score of 23.87, was considered to be cut-o . According to this cut-o value, patients are separated into two categories. Kaplan-Meier method was used to identify factors associated with the overall survival. Results: There was no statistical di erence in the mean HALP score according to gender, tumour localisation, histological type, TNM stage, and adjuvant or palliative chemotherapy groups. The mean HALP score was signi cantly lower in those older than 64 years (p=0.04). When all the patients were divided into the low and high HALP scores, gender, age, histological subtypes, tumour location, adjuvant or palliative treatment status, TNM stage, CEA, and CA19-9 levels were statistically similar between the two groups. A signi cant di erence was found in overall survival of the patients with low and high HALP groups (p=0.05). There was an insigni cant di erence in the overall survival of those with low and high HALP scores in the adjuvant and palliative chemotherapy groups. Conclusion: Gastric adenocarcinoma patients with a high HALP score had a better overall survival rate.
Page(s):
1154-1159
DOI:
DOI not available
Published:
Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 9, Year: 2022
Keywords:
albumin
,
Haemoglobin
,
Lymphocyte
,
Platelet
,
Gastric adenocarcinoma
,
HALP score